Metformin Pharmacogenomics
Metformin is a first line therapy for type 2 diabetes, and is one of the most commonly prescribed drugs worldwide. We have recently written a Metformin Pathways Summary that is published in Journal Pharmacogenetics and Genomics.
Metformin effectively lowers both basal and postprandial plasma glucose. However, the glycemic response to